Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05042492
Other study ID # MMS.2020.058
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 14, 2021
Est. completion date November 2023

Study information

Verified date April 2022
Source moveUP bv
Contact Ward Servaes
Phone +32 800 88 008
Email support@moveup.care
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will investigate whether the recovery of muscle function of total knee arthroplasty is accelerated with the use of the gekoTM device along with its effect on reducing symptoms such as oedema and inhibition of the muscle function.


Description:

This study will investigate total knee arthroplasty patients: - One group gets standard of care (i.e. performing exercises & guidance by a physiotherapist via a CE-marked mobile application, called moveUP) - Second group gets standard of care + GekoTM device (i.e. non-invasive neuromuscular electrostimulation applied at the peroneal nerve for 10 days after the operation date.) The primary objective of the study is to assess the post-operative effect of gekoTM on formation of oedema (measured by perometer). The effect of the gekoTM device on the muscle function & the overall recovery will be also investigated. To collect parameters, the patient will be asked to complete questionnaires, including the following patient reported outcomes (PROMs): Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Society Score (KSS), Euroqol Health questionnaire EQ5D, Forgotten Joint Score (FJS), Oxford Knee Score (OKS). The collection of the PROMs will give an indication on outcome and overal recovery in the 2 groups.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date November 2023
Est. primary completion date July 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Primary TKA planned for degenerative OA - Subjects must be discharged to home environment and be able to independently perform the activities of daily life - Obtain a written informed consent Exclusion Criteria: - TED stockings, Dauerbinde, other compressive bandages - Mechanical foot pump - Cooling device type 'Game Ready' - Posttraumatic OA of the knee - History of DVT / Flebitis / Pulmonary embolism - Surgical treatment of venous insufficiency <1y prior to TKA surgery - Neurological deficit of lower limbs - Current sciatic irradiating pain in lower limbs - History of lumbar fusion - Knee Arthroscopy of the involved limb <6m prior to TKA surgery - Any per-operative complication related to the TKA procedure (bleeding, fracture, vascular injury, cardiac complication, pulmonary complication) - In case of a release during the TKA procedure - Any per-operative (e.g. epidural catheter, urethral catheter, intra articular catheter) or post-operative procedure that might interfere with the rehabilitation during and after hospitalization - Any scheduled surgery in the 3 months following the reference surgery; - Any significant medical condition (e.g. Parkinson's disease, multiple sclerosis, cerebral vascular accident) that might interfere with the rehabilitation - Any significant psychiatric disorders, active alcohol/drug abuse - Subject is either pregnant or interested in becoming pregnant during the duration of the study - Subjects who are currently involved in any investigational drug or device study or have been enrolled in such study within the last 3 months

Study Design


Intervention

Device:
gekoTM
The gekoTM device is a small, transcutaneous nerve stimulator that is placed non-invasively on the skin, whereby the surface electrodes will be attached close to the peroneal nerve. Activation of the peroneal nerve causes contraction of the calf muscle pump, which will increase blood circulation that corresponds to 60% of walking. The increased blood circulation reduces the pressure difference between capillaries and the surrounding tissue and transfers the tissue fluid back into the veins and lymph fibers

Locations

Country Name City State
Belgium AZ maria middelares Ghent East-Flanders

Sponsors (2)

Lead Sponsor Collaborator
moveUP bv Firstkind Ltd

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary objective of the study is to assess the post-operative effect of gekoTM on formation of oedema following Total Knee Arthroplasty (TKA) This is measured by the use of a perometer. For each patient, change in limb volume shall be calculated as a percentage of original limb volume.
Shapiro-Wilk test shall be used to test whether there is a significant (p<0.05) departure from normal distribution in either group.
until end of rehabilitation (+- 3 months after TKA operation)
Secondary Incidence of Adverse Events Any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in subjects, users or other persons, in the context of a clinical investigation, whether or not related to the investigational device.
(MDR Article 2(57)). The total number adverse events and the total number (%) of patients that had at least 1 adverse event will be stated.
until end of rehabilitation (+- 3 months after TKA operation)
Secondary Incidence of Device Deficiency Any inadequacy in the identity, quality, durability, reliability, safety or performance of an investigational device, including malfunction, use errors or inadequacy in information supplied by the manufacturer.(MDR Article 2(59)) during 10 days after TKA operation
Secondary Oedema measurements - subjective slider Temperature/swelling: Identical subjective slider as daily evaluated by the patient itself presenting the result as a Visual Analog Scale score, minimum 0 (no swelling) maximum 100 (Very swollen) until end of rehabilitation (+- 3 months after TKA operation)
Secondary Oedema measurements - photographic evaluation picture of both knees (moveUP): Patients need to make a picture of both knees, using the photo camera on their smartphone to see the swelling of the operated leg compared to the non-operated leg and to evaluate the swelling of the operated leg.
This blind assessment of pictures is performed by a physical therapist.
until end of rehabilitation (+- 3 months after TKA operation)
Secondary Patient Reported Outcome Measures (PROM's) The PROMS's measured:
- KOOS: Knee injury and Osteoarthritis Outcome Score for Joint Replacement. 42 items on 5-point Likert scale (multiple choice), total score is on 100, lower scores being indicative of worse knee conditions and higher scores being indicative of better knee condition
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Patient Reported Outcome Measures (PROM's) The PROMS's measured:
- KSS: Knee Satisfaction Score. Multiple choice scale. Total score on 100, lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Patient Reported Outcome Measures (PROM's) The PROMS's measured:
- EQ5-D: Euroqol Health questionnaire. 5 items on 5-point Likert scale (multiple choice). Total score on 100. Secondly there is also 1 visual analog scale (VAS). The VAS Score is scored separately with lower scores being indicative of worse health and higher scores being indicative of better health (generic questionnaire, not disease specific)
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Patient Reported Outcome Measures (PROM's) The PROMS's measured:
- OKS: Oxford Knee Score. 12 items Multiple choice. a lower score can be indicative for bad function or pain after TKA
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Patient Reported Outcome Measures (PROM's) The PROMS's measured:
- FJS: Forgotten Joint score. 12-item mutiple choice score. Total score on 100 (%), lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.
2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Pain level Visual analogue scale (VAS), a 0-100 scale with 100 score = the worst pain the patient can feel and 0 = the patient feels no pain 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Number of days of Painkiller intake PK intake stop is defined as no PK consumption for 3 consecutive days with no new 3 day-period of PK intake. 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Dosage Painkiller intake 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Number of days of NSAID intake NSAID intake stop is defined as no NSAID consumption for 3 consecutive days with no new 3 day-period of NSAID intake. 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Dosage NSAID intake 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Sleep duration the wearable measures accelerations during 23h-8h and gives an assumption duration of sleep during the night. The assumption of amount of sleep is based on: very little registration (deep sleep), little movements (light sleep), a lot of movements (waking up). 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Sleep quality the wearable measures accelerations during 23h-8h and gives an assumption quality of sleep during the night. The assumption of amount of sleep is based on: very little registration (deep sleep), little movements (light sleep), a lot of movements (waking up). 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Recovery of physical activity (PA) number of weeks until post-operative PA level is similar to pre-operative PA level, meaning there is no significant difference between mean post-operative step count (calculated on each post-operative week) and mean pre-operative step count (calculated on 7 days before surgery). 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Number of days of crutches use until end of rehabilitation (+- 3 months after TKA operation)
Secondary Resume driving a car Number of days post-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Overall Net Promotor Score (NPS) of the rehabilitation in general NPS = How likely would you recommend the rehabilitation to your friends or family?". Visual analogue scale (VAS), a 0-100 scale with 100 score = very likely and 0 = not likely 2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Secondary Satisfaction and feedback on the geko device (only for patients using the geko) Including:
Ease of use
Required level of stimulation (1 to 11)
Adherence to the geko use: daily collection of number of hours worn during the 10 days the geko device is used
during 10 days after TKA operation
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02881775 - Immediate Effects of rTMS on Excitability of the Quadriceps With Knee Osteoarthritis N/A